"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","cell type:ch1","cellular portion:ch1","passages:ch1"
"GSM2834518","A549.Scrb.1","GSM2834518","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842066","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338871","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834519","A549.Scrb.2","GSM2834519","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842094","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338872","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834520","A549.Scrb.3","GSM2834520","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842065","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338873","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834521","A549.Scrb.4","GSM2834521","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842097","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338874","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834522","A549.1735.1","GSM2834522","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842092","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338875","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834523","A549.1735.2","GSM2834523","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842093","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338876","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834524","A549.1735.3","GSM2834524","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842096","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338877","NONE","Carcinoma cells","Exosomes","6-8"
"GSM2834525","A549.1735.4","GSM2834525","Public on Oct 28 2017","Oct 27 2017","May 15 2019","SRA","1","Lung epithelial cells","Homo sapiens","cell type: Carcinoma cells","cellular portion: Exosomes","passages: 6-8","None","A549 cells were plated in T-25 flask at 2x106 density and cultivated in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C in 5% CO2 overnight. Then, cells were washed 3 times with PBS and cultured in DMEM media supplemented with 10% exosome-depleted FBS (System Biosciences, Inc. (SBI), Palo Alto, CA) for 48 hours","total RNA","Exosomes were isolated from cell culture media using using ExoQuick-TCTM (SBI), and microRNA was purified using QIAGEN miRNeasy micro kit (QIAGEN, Valencia, CA) per the manufacture’s protocols","Libraries were prepared according to standard Ilumina's instructions","9606","microRNAs","miRNA sequencing short reads were aligned to human reference genome (GRCh38) using Bowtie2 (v2.2.3) ;","Aligned sequences were mapped to mature miRNAs with annotation from miRBase (v.21);","The relative expression abundances of miRNAs were calculated as Count-Per-Million (CPM).","Supplementary_files_format_and_content: CPM","GPL16791","Tanyalak,,Parimon","tanyalak.parimon@cshs.org","Peter Chen","Medicine","Cedars-Sinai Medical Center","127 San Vicente","Los Angeles","CA","90048","USA","0","Illumina HiSeq 2500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07842095","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3338878","NONE","Carcinoma cells","Exosomes","6-8"
